UBS Group AG Buys 443,459 Shares of Nano-X Imaging Ltd. $NNOX

UBS Group AG lifted its stake in Nano-X Imaging Ltd. (NASDAQ:NNOX) by 40.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,530,104 shares of the company’s stock after acquiring an additional 443,459 shares during the quarter. UBS Group AG owned 2.34% of Nano-X Imaging worth $4,284,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently made changes to their positions in the company. AQR Capital Management LLC purchased a new stake in Nano-X Imaging during the first quarter valued at approximately $178,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Nano-X Imaging by 232.4% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,160,806 shares of the company’s stock valued at $10,793,000 after buying an additional 1,510,806 shares during the last quarter. Geode Capital Management LLC increased its holdings in Nano-X Imaging by 17.5% during the second quarter. Geode Capital Management LLC now owns 810,322 shares of the company’s stock valued at $4,189,000 after buying an additional 120,460 shares during the last quarter. Cetera Investment Advisers increased its holdings in Nano-X Imaging by 82.0% during the second quarter. Cetera Investment Advisers now owns 48,056 shares of the company’s stock valued at $248,000 after buying an additional 21,657 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its holdings in Nano-X Imaging by 61.5% during the second quarter. JPMorgan Chase & Co. now owns 65,783 shares of the company’s stock valued at $340,000 after buying an additional 25,048 shares during the last quarter. 21.49% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

NNOX has been the subject of a number of research reports. Zacks Research cut shares of Nano-X Imaging from a “hold” rating to a “strong sell” rating in a report on Wednesday, April 22nd. D. Boral Capital reaffirmed a “buy” rating and set a $5.00 target price on shares of Nano-X Imaging in a report on Monday, April 20th. Cantor Fitzgerald raised shares of Nano-X Imaging to a “strong-buy” rating in a report on Wednesday, March 4th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Nano-X Imaging in a report on Friday, April 10th. Three investment analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $5.00.

Nano-X Imaging Price Performance

NNOX opened at $1.84 on Friday. The firm has a market cap of $128.05 million, a P/E ratio of -1.16 and a beta of 1.19. Nano-X Imaging Ltd. has a 1-year low of $1.59 and a 1-year high of $5.72. The company has a 50 day simple moving average of $2.14 and a two-hundred day simple moving average of $2.71.

Nano-X Imaging (NASDAQ:NNOX) last posted its quarterly earnings results on Monday, April 20th. The company reported ($0.50) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.35). The firm had revenue of $3.72 million during the quarter, compared to the consensus estimate of $3.99 million. Nano-X Imaging had a negative return on equity of 64.65% and a negative net margin of 790.87%.During the same quarter in the previous year, the company earned ($0.21) earnings per share. Equities analysts anticipate that Nano-X Imaging Ltd. will post -0.65 earnings per share for the current year.

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.